Improving immunogenicity of influenza virus H7N9 recombinant hemagglutinin for vaccine development
Human infections of novel avian influenza A virus (H7N9) emerged in early 2013 and
caused about 40% case-fatality through 2017. Therefore, development of influenza H7N9 …
caused about 40% case-fatality through 2017. Therefore, development of influenza H7N9 …
Improving immunogenicity of influenza virus H7N9 recombinant hemagglutinin for vaccine development
L Ting Hui, MY Chia, CY Lin, YQ Yeh, US Jeng, WG Wu… - 2019 - 211.76.174.198
Human infections of novel avian influenza A virus (H7N9) emerged in early 2013 and
caused about 40% case-fatality through 2017. Therefore, development of influenza H7N9 …
caused about 40% case-fatality through 2017. Therefore, development of influenza H7N9 …
[PDF][PDF] Improving immunogenicity of influenza virus H7N9 recombinant hemagglutinin for vaccine development
MS Lee - Vaccine, 2019 - nsrrc.org.tw
abstract Human infections of novel avian influenza A virus (H7N9) emerged in early 2013
and caused about 40% case-fatality through 2017. Therefore, development of influenza …
and caused about 40% case-fatality through 2017. Therefore, development of influenza …
Improving immunogenicity of influenza virus H7N9 recombinant hemagglutinin for vaccine development
MY Chia, CY Lin, YQ Yeh, US Jeng, WG Wu… - …, 2019 - pubmed.ncbi.nlm.nih.gov
Human infections of novel avian influenza A virus (H7N9) emerged in early 2013 and
caused about 40% case-fatality through 2017. Therefore, development of influenza H7N9 …
caused about 40% case-fatality through 2017. Therefore, development of influenza H7N9 …
Improving immunogenicity of influenza virus H7N9 recombinant hemagglutinin for vaccine development.
LTH Lin TingHui, CMY Chia MinYuan… - 2019 - cabidigitallibrary.org
Human infections of novel avian influenza A virus (H7N9) emerged in early 2013 and
caused about 40% case-fatality through 2017. Therefore, development of influenza H7N9 …
caused about 40% case-fatality through 2017. Therefore, development of influenza H7N9 …
Improving immunogenicity of influenza virus H7N9 recombinant hemagglutinin for vaccine development
L Ting Hui, MY Chia, CY Lin, YQ Yeh, US Jeng, WG Wu… - 2019 - ir.nhri.edu.tw
Human infections of novel avian influenza A virus (H7N9) emerged in early 2013 and
caused about 40% case-fatality through 2017. Therefore, development of influenza H7N9 …
caused about 40% case-fatality through 2017. Therefore, development of influenza H7N9 …
Improving immunogenicity of influenza virus H7N9 recombinant hemagglutinin for vaccine development
L Ting Hui, MY Chia, CY Lin, YQ Yeh, US Jeng, WG Wu… - 2019 - ir.nhri.org.tw
Human infections of novel avian influenza A virus (H7N9) emerged in early 2013 and
caused about 40% case-fatality through 2017. Therefore, development of influenza H7N9 …
caused about 40% case-fatality through 2017. Therefore, development of influenza H7N9 …
Improving immunogenicity of influenza virus H7N9 recombinant hemagglutinin for vaccine development.
MY Chia, CY Lin, YQ Yeh, US Jeng, WG Wu, MS Lee - Vaccine, 2019 - europepmc.org
Improving immunogenicity of influenza virus H7N9 recombinant hemagglutinin for vaccine
development. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe …
development. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe …